Related Experiment Video
Updated: Oct 18, 2025
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications
Aleksander Salomon-Perzyński1, Krzysztof Jamroziak2, Eliza Głodkowska-Mrówka3,4,5
1Department of Hematology, Institute of Hematology and Transfusion Medicine, 14 I. Gandhi St., 02-776 Warsaw, Poland.
Abstract:
Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone marrow plasma cells. Malignant transformation of plasma cells depends on the continuity of events resulting in a sequence of well-defined disease stages, from monoclonal gammopathy of undetermined significance (MGUS) through smoldering myeloma (SMM) to symptomatic multiple myeloma (MM). Evolution of a pre-malignant cell into a malignant cell, as well as further tumor progression, dissemination, and relapse, require development of multiple driver lesions conferring selective advantage of the dominant clone and allowing subsequent evolution under selective pressure of microenvironment and treatment. This process of natural selection facilitates tumor plasticity leading to the formation of genetically complex and heterogenous tumors that are notoriously difficult to treat. Better understanding of the mechanisms underlying tumor evolution in MM and identification of lesions driving the evolution from the premalignant clone is therefore a key to development of effective treatment and long-term disease control. Here, we review recent advances in clonal evolution patterns and genomic landscape dynamics of MM, focusing on their clinical implications.
Insights
Understanding tumor evolution in plasma cell dyscrasias, from monoclonal gammopathy of undetermined significance to multiple myeloma, is key. Identifying genetic drivers aids in developing effective treatments for these complex diseases.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Plasma cell dyscrasias involve abnormal bone marrow plasma cell expansion.
- Disease progression follows stages: monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma (SMM), and symptomatic multiple myeloma (MM).
- Tumor evolution requires genetic driver mutations for clone selection and adaptation.
Purpose of the Study:
- To review advances in understanding clonal evolution patterns in multiple myeloma.
- To explore genomic landscape dynamics in multiple myeloma progression.
- To highlight the clinical implications of these evolutionary mechanisms.
Main Methods:
- Review of recent scientific literature on plasma cell dyscrasias and multiple myeloma.
- Analysis of studies focusing on genetic alterations and clonal dynamics.
- Synthesis of findings related to disease progression and treatment resistance.
Main Results:
- Tumor evolution in multiple myeloma is driven by accumulating genetic lesions under selective pressures.
- This process leads to genetically complex and heterogeneous tumors.
- Understanding these dynamics is crucial for therapeutic strategies.
Conclusions:
- Elucidating mechanisms of tumor evolution in multiple myeloma is essential for effective treatment.
- Identifying early driver lesions can inform strategies for disease control.
- Advances in genomic analysis provide insights into myeloma plasticity and resistance.
More Related Videos
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Related Concept Videos
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:15Differentiation of Common Myeloid Progenitor Cells